AAAAAA
Results:
1-22
|
Results: 22
Authors:
Curvers, J
Nienhuis, SJ
Nap, AW
Hamulyak, K
Evers, JLH
Rosing, J
Citation: J. Curvers et al., Activated protein C resistance during in vitro fertilization treatment, EUR J OB GY, 95(2), 2001, pp. 222-224
Authors:
de Vries, JE
Wijnen, PAHM
Hamulyak, K
van Dieijen-Visser, MP
Bekers, O
Citation: Je. De Vries et al., PCR on cell lysates obtained from whole blood circumvents DNA isolation, CLIN CHEM, 47(9), 2001, pp. 1701-1702
Authors:
Curvers, J
Nap, AW
Thomassen, MCLGD
Nienhuis, SJ
Hamulyak, K
Evers, JLH
Tans, G
Rosing, J
Citation: J. Curvers et al., Effect of in vitro fertilization treatment and subsequent pregnancy on theprotein C pathway, BR J HAEM, 115(2), 2001, pp. 400-407
The risk of pregnancy-related venous thromboembolism in women who are homozygous for factor V Leiden
Authors:
Middeldorp, S
Libourel, EJ
Hamulyak, K
van der Meer, J
Buller, HR
Citation: S. Middeldorp et al., The risk of pregnancy-related venous thromboembolism in women who are homozygous for factor V Leiden, BR J HAEM, 113(2), 2001, pp. 553-555
Authors:
Nijziel, M
van Oerle, R
van 't Veer, C
van Pampus, E
Lindhout, T
Hamulyak, K
Citation: M. Nijziel et al., Tissue factor activity in human monocytes is regulated by plasma: implications for the high and low responder phenomenon, BR J HAEM, 112(1), 2001, pp. 98-104
Authors:
Rosado, JA
Meijer, EMY
Hamulyak, K
Novakova, I
Heemskerk, JWM
Sage, SO
Citation: Ja. Rosado et al., Fibrinogen binding to the integrin alpha(IIb)beta(3) modulates store-mediated calcium entry in human platelets, BLOOD, 97(9), 2001, pp. 2648-2656
Authors:
Hull, RD
Pineo, GF
Stein, PD
Mah, AF
MacIsaac, SM
Dahl, OE
Ghali, WA
Butcher, MS
Brant, RF
Bergqvist, D
Hamulyak, K
Francis, CW
Marder, VJ
Raskob, GE
Citation: Rd. Hull et al., Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty - A systematic review, ARCH IN MED, 161(16), 2001, pp. 1952
Authors:
Middeldorp, S
Meinardi, JR
Koopman, MMW
van Pampus, ECM
Hamulyak, K
van der Meer, J
Prins, MH
Buller, HR
Citation: S. Middeldorp et al., A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism, ANN INT MED, 135(5), 2001, pp. 322-327
Authors:
Braam, LAJLM
Dissel, P
Gijsbers, BLMG
Spronk, HMH
Hamulyak, K
Soute, BAM
Debie, W
Vermeer, C
Citation: Lajlm. Braam et al., Assay for human matrix Gla protein in serum - Potential applications in the cardiovascular field, ART THROM V, 20(5), 2000, pp. 1257-1261
Authors:
Nijziel, MR
van Oerle, R
van Pampus, ECM
de Vet, HCW
Hillen, HFP
Hamulyak, K
Citation: Mr. Nijziel et al., Increased D-dimer levels correlate with binding of activated protein C, but not tissue factor expression, on peripheral blood monocytes in cancer patients, AM J HEMAT, 64(4), 2000, pp. 282-286
Authors:
Keularts, IMLW
Hamulyak, K
Hemker, HC
Beguin, S
Citation: Imlw. Keularts et al., The effect of DDAVP infusion on thrombin generation in platelet-rich plasma of von Willebrand type 1 and in mild haemophilia A patients, THROMB HAEM, 84(4), 2000, pp. 638-642
Authors:
Knapen, MHJ
Hellemons-Boode, BSP
Langenberg-Ledeboer, M
Knottnerus, JA
Hamulyak, K
Price, PA
Vermeer, C
Citation: Mhj. Knapen et al., Effect of oral anticoagulant treatment on markers for calcium and bone metabolism, HAEMOSTASIS, 30(6), 2000, pp. 290-297
Authors:
Hamulyak, K
van der Graaf, F
Janssen, MCH
de Moerloose, P
Michiels, JJ
Citation: K. Hamulyak et al., Exclusion of deep vein thrombosis with rapid ELISA D-dimer testing: From theory to daily practice, CL APPL T-H, 5(4), 1999, pp. 216-219
Authors:
Michiels, JJ
van der Meer, J
Hamulyak, K
Wollersheim, H
Oortwijn, WJ
Naaborg, R
Citation: Jj. Michiels et al., Diagnosis of deep vein thrombosis by the use of a rapid ELISA D-dimer test, CUS, and a clinical model: A cost-effectiveness analysis, CL APPL T-H, 5(4), 1999, pp. 219-221
Authors:
Sanson, BJ
Lensing, AWA
Prins, MH
Ginsberg, JS
Barkagan, ZS
Lavenne-Pardonge, E
Brenner, B
Dulitzky, M
Nielsen, JD
Boda, Z
Turi, S
MacGillavry, MR
Hamulyak, K
Theunissen, IM
Hunt, BJ
Buller, HR
Citation: Bj. Sanson et al., Safety of low-molecular-weight heparin in pregnancy: A systematic review, THROMB HAEM, 81(5), 1999, pp. 668-672
Authors:
Huvers, FC
De Leeuw, PW
Houben, AJHM
De Haan, CHA
Hamulyak, K
Schouten, H
Wolffenbuttel, BHR
Schaper, NC
Citation: Fc. Huvers et al., Endothelium-dependent vasodilatation, plasma markers of endothelial function, and adrenergic vasoconstrictor responses in type 1 diabetes under near-normoglycemic conditions, DIABETES, 48(6), 1999, pp. 1300-1307
Authors:
Maessen-Visch, MB
Koedam, I
Hamulyak, K
Neumann, HAM
Citation: Mb. Maessen-visch et al., Atrophie blanche, INT J DERM, 38(3), 1999, pp. 161-172
Authors:
Curvers, J
Thomassen, MCLGD
Nicolaes, GAF
van Oerle, R
Hamulyak, K
Hemker, HC
Tans, G
Rosing, J
Citation: J. Curvers et al., Acquired APC resistance and oral contraceptives: differences between two functional tests, BR J HAEM, 105(1), 1999, pp. 88-94
Authors:
Meinardi, JR
Pelsma, PM
Koning, H
van der Meer, J
Middeldorp, S
Buller, HR
Hamulyak, K
Citation: Jr. Meinardi et al., Double-homozygosity for factor V Leiden and the prothrombin gene G20210A variant in a young patient with idiopathic venous thrombosis, BLOOD, 94(5), 1999, pp. 1828-1829
Authors:
Maessen-Visch, MB
Hamulyak, K
Tazelaar, DJ
Crombag, NHCMN
Neumann, HAM
Citation: Mb. Maessen-visch et al., The prevalence of factor V Leiden mutation in patients with leg ulcers andvenous insufficiency, ARCH DERMAT, 135(1), 1999, pp. 41-44
Authors:
Meinardi, JR
Middeldorp, S
de Kam, PJ
Koopman, MMW
van Pampus, ECM
Hamulyak, K
Prins, MH
Buller, HR
van der Meer, J
Citation: Jr. Meinardi et al., Increased risk for fetal loss in carriers of the factor V Leiden mutation, ANN INT MED, 130(9), 1999, pp. 736-739
Authors:
Michiels, JJ
Hamulyak, K
Citation: Jj. Michiels et K. Hamulyak, Laboratory diagnosis of hereditary thrombophilia, SEM THROMB, 24(4), 1998, pp. 309-320
Risultati:
1-22
|